Luc Furic ESA-SRB-APEG-NZSE 2022

Abstracts this author is presenting:

• PMR-116, a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer — ESA/NZSE Basic Science & Clinical Orals - Oncology